Toxicity and hemodynamic effects after single dose administration of MalPEG-hemoglobin (MP4) in rhesus monkeys

Area of Science:

• Biomedical Engineering
• Pharmacology
• Toxicology

Background:

• Hemoglobin-based oxygen carriers (HBOCs) are developed as artificial blood substitutes.
• Maleimide-polyethylene glycol-modified hemoglobin (MP4) is a type of HBOC designed for enhanced stability and reduced toxicity.
• Evaluating the safety and hemodynamic profile of novel HBOCs is crucial before clinical application.

Purpose of the Study:

• To assess the potential toxicity of a single dose of MP4 administered via exchange transfusion in rhesus monkeys.
• To evaluate the hemodynamic effects of MP4 in a preclinical setting.
• To determine the safety profile of MP4 as a potential blood substitute.

Main Methods:

• Rhesus monkeys received MP4 (30% of estimated blood volume) or lactated Ringer's solution (LR) via exchange transfusion.
• Toxicity was assessed through clinical chemistry, hematology, necropsy, and histopathology at 3 and 13 days post-dosing.
• Hemodynamic parameters (arterial pressure, heart rate, electrocardiogram) were monitored via telemetry for 7 days.

Main Results:

• MP4 administration resulted in only modest, transient elevations in liver enzymes (AST, ALT, LDH) and mild anemia due to hemodilution.
• Histopathology revealed foamy macrophages in spleen and bone marrow, indicating test article accumulation.
• No significant changes in arterial pressure, heart rate, or electrocardiogram were observed post-MP4 administration.

Conclusions:

• MP4 demonstrated no significant toxicity or adverse hemodynamic effects in rhesus monkeys at a 30% exchange transfusion volume.
• The observed changes were mild, transient, and consistent with the expected profile of an HBOC.
• MP4 is considered safe and hemodynamically inert under the conditions tested, supporting further investigation as a blood substitute.